Steris (STE) Cost of Revenue (2018 - 2026)

Steris has reported Cost of Revenue for 8 years, with the latest figure at $840.7 million in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue rose 10.59% year-over-year to $840.7 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 billion (up 6.67% YoY), and the FY2025 full-year result was $3.1 billion, up 4.66% from the prior year.
• Cost of Revenue for Q4 2025 stood at $840.7 million, up from $814.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $840.7 million in Q4 2025, with the low at $493.7 million in Q1 2021.
• Average Cost of Revenue over 5 years is $700.7 million, with a median of $711.9 million recorded in 2021.
• Year-over-year, Cost of Revenue surged 68.19% in 2021 and fell 15.07% in 2022.
• Tracing STE's Cost of Revenue over 5 years: stood at $670.9 million in 2021, then fell by 5.46% to $634.2 million in 2022, then advanced by 16.31% to $737.7 million in 2023, then gained by 3.05% to $760.2 million in 2024, then rose by 10.59% to $840.7 million in 2025.
• The last three Cost of Revenue figures came in at $840.7 million (Q4 2025), $814.4 million (Q3 2025), and $763.1 million (Q2 2025), per Business Quant data.

Peer Comparison